Things I consider when introducing a new flow cytometry tube, Fiona Craig.  I describe the things I consider when introducing a new flow cytometry tube and include some resources that I have found useful.  Please feel free to comment.  Is this what you do?  Are there any other resources you would like to share with other members of ICCS?

2011 ICSH/ICCS Lab Developed Test (LDT) Validation Consensus Meeting - Holden, Maine, Teri Oldaker and Bruce Davis.  Early in the period of the FDA announcing their intent to become more actively involved in the regulation of LTD assay, a core group of organizers consisting of Brent Wood, Bruce Davis, David Barnett and Teri Oldaker decided to be proactive and organize a consensus meeting. 

Educational Lecture Series, Paul Wallace. The ICCS Education Committee announces the addition of a new section to the ICCS web site.  This section contains contributions by experts in their respective areas on topics of interest to the clinical flow cytometry community. 

Implementing A Higher Color Flow Cytometry System –Summary of Experiences (and possibly a guide to future converts), Anand S. Lagoo.  Many clinical flow cytometry laboratories are examining the pros and cons of switching to higher color analyses.  Whether it’s switching from a four or five color assay to a new 8 (or more) color instrument, or adding one more color, implementation of a higher color assay may seem a daunting task.  In order to provide this actual user feedback, we have gathered information from individuals who have completed or are completing a switch to a higher color flow cytometry platform for clinical analysis.

Case Study Interpretation (CSI)

Archive
View previous issues of the ICCS eNewslettter.